Introducing a new test for the quantitative determination of antibodies against the SARS-CoV-2 spike protein - Roche Elecsys® Anti-SARS-CoV-2 S.

Our Haem-Oncology team is introducing rapid genetic testing to help with the treatment management of leukaemia patients.